Papillary muscle intervention vs mitral ring annuloplasty in ischemic mitral regurgitation.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 18 1 2020
medline: 12 9 2020
entrez: 18 1 2020
Statut: ppublish

Résumé

The main pathophysiological factor of chronic ischemic mitral regurgitation (MR) is the outward displacement of the papillary muscles (PMs) leading to leaflet tethering. For this reason, papillary muscle intervention (PMI) in combination with mitral ring annuloplasty (MRA) has recently been introduced into clinical practice to correct this displacement, and to reduce the recurrence of regurgitation. A meta-analysis was conducted comparing the outcomes of PMI and MRA performed in combination vs MRA performed alone, in terms of MR recurrence and left ventricular reverse remodeling (LVRR). A meta-regression was carried out to investigate the impact of the type of PMI procedure on the outcomes. MR recurrence in patients undergoing both PMI and MRA was lower than in those who only had MRA (log incidence rate ratio, -0.66; lower-upper limits, -1.13 to 0.20; I Using PMI and MRA together has a lower MR recurrence than using MRA alone. No significant LVRR was observed between the two groups nor between the PMI techniques employed.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
The main pathophysiological factor of chronic ischemic mitral regurgitation (MR) is the outward displacement of the papillary muscles (PMs) leading to leaflet tethering. For this reason, papillary muscle intervention (PMI) in combination with mitral ring annuloplasty (MRA) has recently been introduced into clinical practice to correct this displacement, and to reduce the recurrence of regurgitation.
METHODS METHODS
A meta-analysis was conducted comparing the outcomes of PMI and MRA performed in combination vs MRA performed alone, in terms of MR recurrence and left ventricular reverse remodeling (LVRR). A meta-regression was carried out to investigate the impact of the type of PMI procedure on the outcomes.
RESULTS RESULTS
MR recurrence in patients undergoing both PMI and MRA was lower than in those who only had MRA (log incidence rate ratio, -0.66; lower-upper limits, -1.13 to 0.20; I
CONCLUSIONS CONCLUSIONS
Using PMI and MRA together has a lower MR recurrence than using MRA alone. No significant LVRR was observed between the two groups nor between the PMI techniques employed.

Identifiants

pubmed: 31951676
doi: 10.1111/jocs.14407
pmc: PMC7078820
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

645-653

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals, Inc.

Références

J Am Coll Cardiol. 2016 May 24;67(20):2334-2346
pubmed: 27199056
Circulation. 2006 Jul 4;114(1 Suppl):I529-34
pubmed: 16820632
J Thorac Cardiovasc Surg. 2008 Aug;136(2):507-18
pubmed: 18692665
Am J Physiol. 1995 Dec;269(6 Pt 2):H2100-8
pubmed: 8594922
Circulation. 2007 Sep 11;116(11 Suppl):I259-63
pubmed: 17846314
Eur Heart J. 2008 Jan;29(2):231-40
pubmed: 17989079
Circulation. 2000 Jun 13;101(23):2756-63
pubmed: 10851215
Ann Thorac Surg. 2004 Jun;77(6):1989-97
pubmed: 15172252
Ann Thorac Surg. 2009 Jun;87(6):1721-6; discussion 1726-7
pubmed: 19463585
Ann Thorac Cardiovasc Surg. 2015;21(4):370-7
pubmed: 25740449
J Thorac Cardiovasc Surg. 2010 Dec;140(6):1312-8
pubmed: 20347098
Ann Cardiothorac Surg. 2015 Sep;4(5):411-6
pubmed: 26539344
Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):261-268
pubmed: 28043427
J Am Coll Cardiol. 1992 Apr;19(5):1101-5
pubmed: 1552101
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120
J Cardiol. 2008 Jun;51(3):145-56
pubmed: 18522789
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
PLoS Med. 2009 Jul 21;6(7):e1000100
pubmed: 19621070
Eur Heart J. 2010 Dec;31(24):2996-3005
pubmed: 21123277
Heart. 2003 Apr;89(4):459-64
pubmed: 12639884
Interact Cardiovasc Thorac Surg. 2008 May;7(3):368-71
pubmed: 18372282
Circulation. 2009 Sep 15;120(11 Suppl):S85-91
pubmed: 19752391
Eur J Cardiothorac Surg. 2005 May;27(5):847-53
pubmed: 15848325
J Epidemiol Community Health. 1998 Jun;52(6):377-84
pubmed: 9764259
Ann Thorac Surg. 2019 Dec;108(6):1783-1792
pubmed: 31254507
Ann Thorac Surg. 2019 Jan;107(1):311-321
pubmed: 29959943
Thorac Cardiovasc Surg. 2012 Jun;60(4):269-74
pubmed: 22549757
Circ J. 2008 Nov;72(11):1737-43
pubmed: 18802311
Eur J Cardiothorac Surg. 2019 Nov 1;56(5):968-975
pubmed: 31005995
Circulation. 2004 Sep 14;110(11 Suppl 1):II85-90
pubmed: 15364844
J Thorac Cardiovasc Surg. 2017 Oct;154(4):1258-1259
pubmed: 28651942
Ann Thorac Surg. 2007 Sep;84(3):745-9
pubmed: 17720370
Semin Thorac Cardiovasc Surg. 2012 Winter;24(4):246-53
pubmed: 23465672
J Thorac Cardiovasc Surg. 2003 Jan;125(1):135-43
pubmed: 12538997
J Am Soc Echocardiogr. 2006 Jan;19(1):71-5
pubmed: 16423672
Eur J Cardiothorac Surg. 2011 Sep;40(3):756-60
pubmed: 21342768
J Thorac Cardiovasc Surg. 2014 Nov;148(5):1947-50
pubmed: 24656671
J Card Surg. 2020 Mar;35(3):645-653
pubmed: 31951676
Circulation. 1991 Nov;84(5):2167-80
pubmed: 1934385
Ann Thorac Surg. 2007 Dec;84(6):2130-1
pubmed: 18036963
Heart Vessels. 2018 Jan;33(1):72-79
pubmed: 28803350

Auteurs

Linda R Micali (LR)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Mohammad N Qadrouh (MN)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Orlando Parise (O)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Gianmarco Parise (G)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Francesco Matteucci (F)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Monique de Jong (M)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Cecilia Tetta (C)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Amalia I Moula (AI)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Daniel M Johnson (DM)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Sandro Gelsomino (S)

Department of Cardiothoracic Surgery, Maastricht University Hospital, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH